DOI: https://doi.org/10.22141/2224-0551.13.7.2018.148921

Recurrent respiratory infections in pediatric practice: the effectiveness of the use of inosine pranobex

T.P. Borysova, L.P. Badogina, Т.В. Fedko

Abstract


The review of literature presents current data on terminology and causes of recurrent respiratory infections in children, the immunological basis for the recurrence of respiratory tract infections in childhood. A scheme of the standard examination of a child with recurrent respiratory infections is presented. Cha­racteristics of inosine pranobex, possessing antiviral and immunomodulatory action, are given. The results of studies on the clinical efficacy of inosine pranobex in recurrent respiratory infections in children are summarized. Dosage and regimens of inosine pranobex use are shown in recurrent respiratory diseases in children.

Keywords


review; recurrent respiratory infections; children; inosine pranobex

References


Abaturov AE, Nikulina AA, Tokareva NM. Effect of treatment with inosine pranobex in acute respiratory viral infections in children. Zdorovʹe rebenka. 2018;13(5):478-483. doi: 10.22141/2224-0551.13.5.2018.141565. (in Russian).

Bulgakova VA. Inosin pranobeks: experience in acute respiratory-viral infections. Uchastkovyi pediatr. 2015;4: 26-28. (in Russian).

Ershov FI. Antivirusnye preparaty: spravochnik [Antiviral drugs: reference book]. 2nd ed. Moscow: GEOTAR-Media; 2006. 312 p. (in Russian).

Zaplatnikov AL. Kliniko-patogeneticheskoe obosnovanie immunoterapii i immunoprofilaktiki virusnykh i bakterial'nykh zabolevanii u detei. Diss. dokt. med. nauk [Clinico-pathogenetic substantiation of immunotherapy and immunoprophylaxis of viral and bacterial diseases in children. Dr. med. sci. diss.]. Moskow; 2003. 233 р. (in Russian).

Zemskov VM. Immunomodulating properties of inosine preparations and their analogues. Uspehi sovremennoj biologii. 1989;107(1):69-78. (in Russian).

Zakharova IN, Cheburkin AV, Malinovskaya VV, et al. The significance of the interferon system for formation of the immune response in children with acute respiratory viral infections. Clinical Practice in Pediatrics. 2009;4(5):38-45. (in Russian).

Ivanova NA. Bronchial obstruction in children: a differentiated approach to diagnosis and management of patients. Pediatrics. Consilium Medicum. 2015;(3):57-61. (in Russian).

Osidak LV, Zarubaev VV, Obraztsova EV, Erman ES, Drinevsky VP. Isoprinosin in the treatment of acute respiratory viral infarction in frequently ill children. Children's Infections. 2008;7(4):35-41. (in Russian).

Bulgakova VA, Balabolkin II, Sedova MS, Shmakova SG, Zubkova IV, Korolkova EL. Clinical and immunological efficacy of inosine pranobex for acute respiratory infections in children with atopic asthma. Pediatricheskaya Farmakologiya. 2010;7(3):98-105. (in Russian).

Zamakhina EV, Fomina VL, Kladova OV, et al. Clinico-pathogenetic significance of the persistence of respiratory viruses in often ill children. Pediatria. 2009;87(3):42-47. (in Russian).

Kramarev SA. Inosin pranobex in the practice of pediatric physician. Paediatrics. Eastern Europe. 2014;(5):70-76. (in Russian).

Kuprina NP, Kokoreva SP, Aralova YeV. Influence of environmental factors on the health status of frequently ill children and the specific features of their immune response. Epidemiologiya i Infektsionnye Bolezni. 2008;(4):32-35. (in Russian).

Lapshin VF, Umanets TR. Rehabilitation of often ill children. Zdorov`ja Ukrai'ny. 2006;(6):21-24. (in Russian).

Lukushkina EF, Baskakova EIu. Rational pharmacotherapy of acute respiratory infections as a prevention of polypharmacy in children. RMJ. 2016;24(18):1187-1190. (in Russian).

Malakhov AB, Kolosova NG, Dronov IA. Treatment and prevention of recurrent respiratory diseases in children. Prakticheskaia pul'monologiia. 2015;1:83-86. (in Russian).

Markova TP. Isoprinosine use for the prophylaxis of recurrent respiratory infections in frequently ill children. Pharmateca. 2009;(5):54-58. (in Russian).

Melnikova IM, Mizernitskiy YuL. Methods of immune correction for recurrent respiratory infections in childhood. Meditsinskiy Sovet. 2015;(14):84-88. (in Russian).

Yulish YeI, Balychevtseva IV, Krivushchev BI, Gadetskaia SG, Iaroshenko SIa. The method of differentiated approach to the treatment and rehabilitation of often and long-term ill children with different persistent infections. Klinichna immunologija. Alergologija. Infektologija. 2010;(31):52-57. (in Russian).

Nedelskaya SN, Yartseva DA. Diagnostics of bronchial asthma in infants: possibilities, topical issues, differential diagnosis. Zdorovʹe rebenka. 2013;(45):108-111. doi: 10.22141/2224-0551.2.45.2013.88245. (in Russian).

Osidak LV, Obraztsova EV. Study results of inosine pranobex inclusion into therapy of acute respiratory viral infections in children. Lechaschii Vrach. 2012;(10):1-4. (in Russian).

Okhotnikova ЕN, Rudenko SN, Kolomiets EN. Recurrent respiratory tract infections in children and their immunoprophylaxis in the terms of modern ideas about immunomodulatory activity of immunotropic preparations. Sovremennaya pediatriya. 2013;(49):42-50. (in Russian).

Paramonova NS, Volkova OA. Problems of acute respiratory viral diseases in pediatrics. Zdorovʹe rebenka. 2010;(23):21-23. (in Russian).

Nisevich LL, Volkov KS, Alekseeva АА, et al. Approaches to the treatment of acute respiratory infections and influenza during the seasonal increase in the incidence of diseases. Voprosy Sovremennoi Pediatrii. 2015;14(1):64-69. (in Russian).

Krasnov V, Kulova A, Kulova E, et al. Rehabilitation in children's closed institutions of often ill children with markers of activity of herpetic infections. Vrach. 2007;(12):70-72. (in Russian).

Chebotareva TA, Mazankova LN, Hoperskova AP, Malinovskaya VV, Koltsov VD, Bragina GS. Recurrent Respiratory Infections in Children and the Program Immunorehabilitation. Children's Infections. 2014;13(3):61-64. doi: 10.22627/2072-8107-2014-13-3-61-64. (in Russian).

Rechkina EA. Often ill children and role of immunocorrection in their treatment. Astma ta alergia. 2013;(1):44-47. (in Russian).

Samsyginа GA. Frequently ill children: problems of pathogenesis, diagnosis, therapy. Pediatria. 2005;1:66-73. (in Russian).

Samsygina GA, Koval’ GS. Problems of diagnosis and treatment of frequently ill children at the present stage. Pediatria. 2010;89(2):137-145. (in Russian).

Serhiyenko EN. Application Groprinosin in pediatric practice: a review of the literature. Meditsinskie novosti. 2016;(9):37-40. (in Russian).

Simovanyan EN, Badalyants EE, Sizyakina LP, Lebedenko AA, Denisenko VB, Kim MA. An improvement of the child acute respiratory infection treatment program. Pediatricheskaya Farmakologiya. 2013;10(1):83-90. (in Russian).

Zinov’evа NV, Davydova NV, Shcherbina AIu, Prodeus AP, Rumiantsev AG. Frequently ill children: what are they really sick? Trudnyj pacient. 2007;5(2):25-27. (in Russian).

Shamsheva OV, Boitsov VP. Experience of using different courses of inosine pranobex in the therapy of acute respiratory viral infection and influenza in children. Lechaschii Vrach. 2013;(8):92-95. (in Russian).

Iakupova RSh, Skachkova MA, Choloian SB, Karpova EG. Efficacy of immunomodulators in children with respiratory diseases in environmentally poor areas. Gig Sanit. 2012 May-Jun;(3):33-4. (in Russian).

Eliseeva MIu, Tsarev VN, Masikhi KN, et al. The effectiveness of auxiliary immunotherapy in patients with immunodeficiency and frequently ill children: a systematic review and meta-analysis of the use of inosine pranobex in ARVI. RMJ. 2010;18(5):313-320. (in Russian).

Ballow M. Approach to the patient with recurrent infections. Clin Rev Allergy Immunol. 2008 Apr;34(2):129-40. doi: 10.1007/s12016-007-8041-2.

Bartlett JG. Management of Respiratory Tract Infections. 3rd ed. Philadelphia: Lippincott Williams&Wilkins; 2001. 277 p.

Bellanti JA. Recurrent respiratory tract infections in paediatric patients. Drugs. 1997;54 Suppl 1:1-4. doi: 10.2165/00003495-199700541-00003.

Campoli-Richards DM, Sorkin EM, Heel RC. Inosine pranobex. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs. 1986 Nov;32(5):383-424. doi: 10.2165/00003495-198632050-00001.

Bitko V, Musiyenko A, Bayfield MA, Maraia RJ, Barik S. Cellular La protein shields nonsegmented negative-strand RNA viral leader RNA from RIG-I and enhances virus growth by diverse mechanisms. J Virol. 2008 Aug;82(16):7977-87. doi: 10.1128/JVI.02762-07.

Kusel MM, de Klerk NH, Kebadze T, Vohma V, Holt PG, Johnston SL, Sly PD. Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma. J Allergy Clin Immunol. 2007 May;119(5):1105-10. doi: 10.1016/j.jaci.2006.12.669.

Khakoo RA, Watson GW, Waldman RH, Ganguly R. Effect of inosiplex (Isoprinosine) on induced human influenza A infection. J Antimicrob Chemother. 1981 Apr;7(4):389-97.

Jansen RR, Wieringa J, Koekkoek SM, et al. Frequent detection of respiratory viruses without symptoms: toward defining clinically relevant cutoff values. J Clin Microbiol. 2011 Jul;49(7):2631-6. doi: 10.1128/JCM.02094-10.

Gern JE. Viral respiratory infection and the link to asthma. Pediatr Infect Dis J. 2008 Oct;27(10 Suppl):S97-103. doi: 10.1097/INF.0b013e318168b718.

Gordon P, Brown ER. The antiviral activity of isoprinosine. Can J Microbiol. 1972 Sep;18(9):1463-70.

Nokso-Koivisto J, Kinnari TJ, Lindahl P, Hovi T, Pitkäranta A. Human picornavirus and coronavirus RNA in nasopharynx of children without concurrent respiratory symptoms. J Med Virol. 2002 Mar;66(3):417-20.

Gołebiowska-Wawrzyniak M, Markiewicz K, Kozar A,et al. Immunological and clinical study on therapeutic efficacy of inosine pranobex. Pol Merkur Lekarski. 2005 Sep;19(111):379-82. (in Polish).

Majewska A, Lasek W, Janyst M, Młynarczyk G. In vitro inhibition of HHV-1 replication by inosine pranobex and interferon-α. Acta Pol Pharm. 2016 May-Jun;73(3):637-44.

Petrova M, Jelev D, Ivanova A, Krastev Z. Isoprinosine affects serum cytokine levels in healthy adults. J Interferon Cytokine Res. 2010 Apr;30(4):223-8. doi: 10.1089/jir.2009.0057.

Jankowski A, Kowalik W, Szyszka Z, Sznajder W, Stasiewicz U, Szenborn L. Isoprinosine and climatotherapy at the Czerniawa-Zdrój health resort in the treatment of children with recurrent respiratory tract infections. Pneumonol Pol. 1989 Mar;57(3):192-5.

Ohnishi H, Kosuzume H, Inaba H, et al. Mechanism of host defense suppression induced by viral infection: mode of action of inosiplex as an antiviral agent. Infect Immun. 1982 Oct;38(1):243-50.

Van Niekerk A, Esser M. A diagnostic approach to recurrent respiratory tract infections in childwood: could it be primary immunodeficiency? Current Allergy & Clinical Immunology. 2015 Dec;28(4):308-312.

Bonilla FA, Bernstein IL, Khan DA, et al. Practice parameter for the diagnosis and management of primary immunodeficiency. Ann Allergy Asthma Immunol. 2005 May;94(5 Suppl 1):S1-63.

Don M, Fasoli L, Gregorutti V, et al. Recurrent respiratory infections and phagocytosis in childhood. Pediatr Int. 2007 Feb;49(1):40-7. doi: 10.1111/j.1442-200X.2007.02296.x.

Slatter MA, Gennery AR. Clinical immunology review series: an approach to the patient with recurrent infections in childhood. Clin Exp Immunol. 2008 Jun;152(3):389-96. doi: 10.1111/j.1365-2249.2008.03641.x.

Sly PD, Kusel M, Holt PG. Do early-life viral infections cause asthma? J Allergy Clin Immunol. 2010 Jun;125(6):1202-5. doi: 10.1016/j.jaci.2010.01.024.

Stenzel T, Tykałowski B, Smiałek M, Koncicki A, Kwiatkowska-Stenzel A. The effect of different doses of methisoprinol on the percentage of CD4+ and CD8+ T lymphocyte subpopulation and the antibody titers in pigeons immunised against PPMV-1. Pol J Vet Sci. 2011;14(3):367-71.

Tregoning JS, Schwarze J. Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology. Clin Microbiol Rev. 2010 Jan;23(1):74-98. doi: 10.1128/CMR.00032-09.




Copyright (c) 2018 CHILD`S HEALTH

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© Publishing House Zaslavsky, 1997-2019

 

   Seo анализ сайта